
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc.(DYN)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
dyn · 股价预测 · 14 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$60.00
Consensus
$37.40
+119.5% upside
Low
$23.00
Median: $38.5 · Last Close: $17.04
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$37.40
119.5% upside
High Target
$60
252.1%
Low Target
$23
35.0%
Current Price
$17.04
as of today
Based on analyst price targets, the DYN stock price prediction for the next 12 months ranges from $23 to $60. The consensus DYN price forecast of $37.40 implies 119.5% upside from the current price of $17.04.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $17.06 | ↑ 0.12% |
1-day model range: $16.93–$17.19. Peak: $17.19 (+0.12%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DYN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-13 | Bernstein | Maintains | Market Perform→Market Perform |
| 2026-03-09 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-03 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-03-03 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-20 | JP Morgan | Maintains | Neutral→Neutral |
| 2025-12-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-12-11 | Stifel | Maintains | Buy→Buy |
| 2025-12-10 | Oppenheimer | Upgrade ↑ | Perform→Outperform |
Wall Street analysts have recently issued updated ratings on Dyne Therapeutics, Inc. (DYN) stock. Of the recent 79 rating actions, 3 were upgrades and 2 were downgrades. 14 analysts currently cover DYN.
分析师推荐趋势
DYN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$1M
↓ 99.7% YoY
Revenue Next Year
$51M
↑ 5050.8% YoY
EPS This Year
$-3.08
EPS Next Year
$-2.94
↓ 4.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast DYN EPS of $-3.08 for the current fiscal year, based on estimates from 12 analysts. The DYN revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DYN 股价预测由两类独立数据源支撑:来自 14 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。DYN 的共识目标价为 $37.40(+119.5% 上行空间),分析师共识为 Buy。
DYN 的短期预测(明日)为 $17.06(+0.12%)。
Dyne Therapeutics, Inc. 在 NASDAQ 上市,代码 DYN。DYN 在 2027 年的整体展望偏积极,在覆盖分析师中约 86% 对应 Buy 共识。
常见问题
DYN 预测 · 8 个问题根据 14 位华尔街分析师,DYN 的 12 个月平均目标价为 $37.40,最高 $60.00、最低 $23.00。若有图表,中位目标价可在上方查看。相对当前价 $17.04,隐含约 +119.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.